Free Trial

C4 Therapeutics (CCCC) Insider Trading & Ownership

C4 Therapeutics logo
$1.49 -0.03 (-1.97%)
Closing price 07/3/2025 03:37 PM Eastern
Extended Trading
$1.48 -0.01 (-1.01%)
As of 07/3/2025 04:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

C4 Therapeutics (NASDAQ:CCCC) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
8.73%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$3.65K
Get CCCC Insider Trade Alerts

Want to know when executives and insiders are buying or selling C4 Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CCCC Insider Buying and Selling by Quarter

C4 Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/18/2025Scott N BoyleInsiderSell669$3.15$2,107.35  
2/14/2025Scott N BoyleInsiderSell490$3.15$1,543.50  
(Data available from 1/1/2013 forward)

CCCC Insider Trading Activity - Frequently Asked Questions

The list of insiders at C4 Therapeutics includes Scott N Boyle, and Utpal Koppikar. Learn more on insiders at CCCC.

8.73% of C4 Therapeutics stock is owned by insiders. Learn more on CCCC's insider holdings.

The following insider sold CCCC shares in the last 24 months: Scott N Boyle ($3,650.85).

Insiders have sold a total of 1,159 C4 Therapeutics shares in the last 24 months for a total of $3,650.85 sold.



This page (NASDAQ:CCCC) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners